Neuroprotective effect of selective kappa opioid receptor agonist is gender specific and linked to reduced neuronal nitric oxide
about
Salvinorin A administration after global cerebral hypoxia/ischemia preserves cerebrovascular autoregulation via kappa opioid receptor in pigletsContributions of poly(ADP-ribose) polymerase-1 and -2 to nuclear translocation of apoptosis-inducing factor and injury from focal cerebral ischemia.Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke.Sex differences in kappa opioid pharmacologyKappa opioid receptor localization and coupling to nitric oxide production in cells of the anterior chamberIn vitro and in vivo efficacy of a potent opioid receptor agonist, biphalin, compared to subtype-selective opioid receptor agonists for stroke treatment.Sex-independent neuroprotection with minocycline after experimental thromboembolic stroke.The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice.Salvinorin A produces cerebrovasodilation through activation of nitric oxide synthase, κ receptor, and adenosine triphosphate-sensitive potassium channel.Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans.Gender-dependent effects of enriched environment and social isolation in ischemic retinal lesion in adult rats.Lack of sex-linked differences in cerebral edema and aquaporin-4 expression after experimental stroke.Heme oxygenase 1 is associated with ischemic preconditioning-induced protection against brain ischemiaThe perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema.Transcriptional and epigenetic regulation of opioid receptor genes: present and future.The influence of stroke risk factors and comorbidities on assessment of stroke therapies in humans and animals.Kappa Opioid Receptor Agonist and Brain Ischemia.Therapeutic time window for conivaptan treatment against stroke-evoked brain edema and blood-brain barrier disruption in mice.Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema.The Role of κ Opioid Receptor in Brain Ischemia.Neuroprotection by the kappa-opioid receptor agonist, BRL52537, is mediated via up-regulating phosphorylated signal transducer and activator of transcription-3 in cerebral ischemia/reperfusion injury in rats.Kappa-opioid receptor agonist U50448H protects against renal ischemia-reperfusion injury in rats via activating the PI3K/Akt signaling pathway.Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.Upregulation of heme oxygenase-1 protected against brain damage induced by transient cerebral ischemia-reperfusion injury in rats.Salvinorin A preserves cerebral pial artery autoregulation after forebrain ischemia via the PI3K/AKT/cGMP pathway.
P2860
Q28481482-0D2DCA01-0577-4657-8CA3-557C943C024AQ33814677-B4A04524-8224-43CB-B770-38E0707D15E7Q33879440-E67144F0-453F-475E-8AF6-B2AAFF33A3BEQ34144003-E3A00913-6D4A-442B-BF3B-D5762BC6DA2FQ35221449-0791E38E-E1AF-4781-B4CD-D137D7683406Q35563036-DD5CBC38-0514-4ADE-9B6B-14E6E2487A16Q35779826-EF51CE5B-FD31-4AE4-95B0-EE63E47B2FD9Q36051056-C88920B1-5483-44A5-AF27-DFFE272B2CCAQ36069379-B0FC7536-B2A2-4651-AA2A-8EEA919B9FDAQ36766665-E5B28433-4CA4-4F97-8EE9-47376B4DF391Q37139130-D9BCC0AC-3BBE-4A2B-9459-F89C67121401Q37154368-9D32CE9D-ADD9-4AA0-B54B-2901D9101B05Q37339694-D2923ECE-DF84-431A-84EE-91830C00A64FQ37371489-F35D6B82-B5A8-4902-BD3E-40A0FE5E0500Q37792084-44A6EF04-E617-429A-8DB4-83334BDF581CQ38019965-3BB7E51C-26F9-4013-A0BD-D8E1246316C2Q38312641-DB71E7E9-14C6-4785-821D-123DBFA20FC9Q38602148-D48B1D93-3C06-449D-912A-128539B782E7Q38816548-79E96363-F000-45D4-906C-7A0A27DE2366Q44339189-A1C1A7AC-7444-4270-ABF8-D913742DDEF2Q44341015-34ED5059-0FE4-468F-9D1E-7B2B2C87B0D2Q44347744-ECD6D42A-FC14-476F-85C6-9A078C5E087DQ53082241-76656AB3-B87A-4B5F-AF0A-0E53051E79A3Q55035443-34019C55-C853-4224-BB11-F50A86DB5F5CQ55428067-F6862D87-6F9E-412B-B8A3-BF4893E1E0F0
P2860
Neuroprotective effect of selective kappa opioid receptor agonist is gender specific and linked to reduced neuronal nitric oxide
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Neuroprotective effect of sele ...... reduced neuronal nitric oxide
@ast
Neuroprotective effect of sele ...... reduced neuronal nitric oxide
@en
Neuroprotective effect of sele ...... reduced neuronal nitric oxide
@nl
type
label
Neuroprotective effect of sele ...... reduced neuronal nitric oxide
@ast
Neuroprotective effect of sele ...... reduced neuronal nitric oxide
@en
Neuroprotective effect of sele ...... reduced neuronal nitric oxide
@nl
prefLabel
Neuroprotective effect of sele ...... reduced neuronal nitric oxide
@ast
Neuroprotective effect of sele ...... reduced neuronal nitric oxide
@en
Neuroprotective effect of sele ...... reduced neuronal nitric oxide
@nl
P2093
P2860
P3181
P356
P1476
Neuroprotective effect of sele ...... reduced neuronal nitric oxide
@en
P2093
Anish Bhardwaj
Emil Zeynalov
Masaaki Nemoto
Patricia D Hurn
Raymond C Koehler
P2860
P304
P3181
P356
10.1038/SJ.JCBFM.9600196
P407
P577
2006-03-01T00:00:00Z